Search results
Results from the WOW.Com Content Network
It mostly affects young to middle-aged female dogs, [9] as the average age at diagnosis being four years old (although it has been found in puppies and dogs up to twelve years old). About seventy percent of dogs that are diagnosed with hypoadrenocorticism are female. [9] Hypoadrenocorticism is still relatively uncommon or underdiagnosed in dogs.
Treatment involves insulin replacement therapy, [95] and use of a diet high in fiber and complex carbohydrates. [96] Oral diabetes medications cannot be used for dogs because none repair or surmount the permanent damage to the beta cells of the pancreas. [88] [97] [98] [99] [List entry too long] Thyroid diseases, including: Hyperthyroidism is ...
Fanconi syndrome or Fanconi's syndrome (English: / f ɑː n ˈ k oʊ n i /, / f æ n-/) is a syndrome of inadequate reabsorption in the proximal renal tubules [1] of the kidney.The syndrome can be caused by various underlying congenital or acquired diseases, by toxicity (for example, from toxic heavy metals), or by adverse drug reactions. [2]
In addition, unabsorbed fatty acids, converted to hydroxy-fatty acids by colonic flora, as well as unabsorbed bile acids both impair absorption and induce secretion of water and electrolytes by the colon adding to stool mass. Weight loss is common among patients with significant intestinal malabsorption but must be evaluated in the context of ...
Pimobendan is indicated for the management of the signs of mild, moderate, or severe congestive heart failure in dogs due to clinical myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM); [1] [7] and for use with concurrent therapy for congestive heart failure (e.g.,furosemide, etc.) as appropriate on a case-by-case basis. [1]
All patients are also given appropriate intravenous fluids and electrolytes. These steps are necessary to reduce the risks of anaesthesia because most patients are older aged dogs. [11] During surgical procedures the whole abdominal cavity is checked in case of any concurrent and or occult problems.
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
Maropitant (INN; [3] brand name: Cerenia, used as maropitant citrate , is a neurokinin-1 (NK 1) receptor antagonist developed by Zoetis specifically for the treatment of motion sickness and vomiting in dogs. It was approved by the FDA in 2007, for use in dogs [4] [5] and in 2012, for cats. [6]